Health for Life Capital, managed by Seventure Partners, realised a new close at €100m.
The aim of Health for Life Capital has been to support innovative high-growth entrepreneurial ventures.
The geographical focus of Health for Life Capital is primarily in Europe, but also extends to North America and Asia. Investment is focused on four areas: microbiota, nutrition, biotech and digital health.
The fund raising has attracted both financial investors, strategic investors and serial entrepreneurs. Jasmin Capital is the placement agent of this fund.
Initial investments have been madein Enterome Bioscience (Paris), LNC (Laboratoires Nutrition & Cardiométabolisme) (Bordeaux), Interface Therapeutics (California, USA), Humedics (Berlin) and MaaT Pharma (Lyon).
Webpage:
- Unquote – Seventure holds second close for biotech fund on EUR 100M
- Capital Finance – Health for Life Capital dispose déjà de 100 M€
- CFNews – Seventure dope son fonds santé
